Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 1
1965 1
1977 1
1980 1
1985 2
1986 1
1989 3
1990 2
1991 7
1992 2
1993 3
1994 7
1995 2
1996 3
1997 5
1998 12
1999 15
2000 14
2001 10
2002 13
2003 6
2004 9
2005 6
2006 5
2007 7
2008 6
2009 4
2010 6
2011 9
2012 5
2013 6
2014 6
2015 4
2016 9
2017 10
2018 11
2019 12
2020 15
2021 12
2022 12
Text availability
Article attribute
Article type
Publication date

Search Results

251 results
Results by year
Filters applied: . Clear all
Page 1
Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial.
Yoshida K, Kodera Y, Kochi M, Ichikawa W, Kakeji Y, Sano T, Nagao N, Takahashi M, Takagane A, Watanabe T, Kaji M, Okitsu H, Nomura T, Matsui T, Yoshikawa T, Matsuyama J, Yamada M, Ito S, Takeuchi M, Fujii M. Yoshida K, et al. Among authors: kochi m. J Clin Oncol. 2019 May 20;37(15):1296-1304. doi: 10.1200/JCO.18.01138. Epub 2019 Mar 29. J Clin Oncol. 2019. PMID: 30925125 Free PMC article. Clinical Trial.
Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07.
Kakeji Y, Yoshida K, Kodera Y, Kochi M, Sano T, Ichikawa W, Lee SW, Shibahara K, Shikano T, Kataoka M, Ishiguro A, Ojima H, Sakai Y, Musha N, Takase T, Kimura T, Takeuchi M, Fujii M. Kakeji Y, et al. Among authors: kochi m. Gastric Cancer. 2022 Jan;25(1):188-196. doi: 10.1007/s10120-021-01224-2. Epub 2021 Aug 5. Gastric Cancer. 2022. PMID: 34351555 Clinical Trial.
[Oligo-astrocytoma].
Kochi M, Ushio Y. Kochi M, et al. Ryoikibetsu Shokogun Shirizu. 2000;(28 Pt 3):51-3. Ryoikibetsu Shokogun Shirizu. 2000. PMID: 11043178 Review. Japanese. No abstract available.
[Schwannoma].
Nishi T, Kochi M, Ushio Y. Nishi T, et al. Among authors: kochi m. Ryoikibetsu Shokogun Shirizu. 2000;(28 Pt 3):121-7. Ryoikibetsu Shokogun Shirizu. 2000. PMID: 11043201 Review. Japanese. No abstract available.
Structural analysis reveals TLR7 dynamics underlying antagonism.
Tojo S, Zhang Z, Matsui H, Tahara M, Ikeguchi M, Kochi M, Kamada M, Shigematsu H, Tsutsumi A, Adachi N, Shibata T, Yamamoto M, Kikkawa M, Senda T, Isobe Y, Ohto U, Shimizu T. Tojo S, et al. Among authors: kochi m. Nat Commun. 2020 Oct 15;11(1):5204. doi: 10.1038/s41467-020-19025-z. Nat Commun. 2020. PMID: 33060576 Free PMC article.
[Neoadjuvant chemotherapy for gastric cancer].
Fujii M, Kochi M, Takayama T. Fujii M, et al. Among authors: kochi m. Gan To Kagaku Ryoho. 2007 Oct;34(10):1549-52. Gan To Kagaku Ryoho. 2007. PMID: 17940370 Review. Japanese.
A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer.
Hasegawa H, Shitara K, Takiguchi S, Takiguchi N, Ito S, Kochi M, Horinouchi H, Kinoshita T, Yoshikawa T, Muro K, Nishikawa H, Suna H, Kodera Y. Hasegawa H, et al. Among authors: kochi m. Gastric Cancer. 2022 May;25(3):619-628. doi: 10.1007/s10120-022-01286-w. Epub 2022 Mar 7. Gastric Cancer. 2022. PMID: 35254550 Free PMC article. Clinical Trial.
Evaluation of Prognosis of Juvenile Differentiated Thyroid Carcinoma.
Tsukioki T, Shien T, Ohtani Y, Fujihara M, Suzuki Y, Kajihara Y, Hatono M, Kawada K, Kochi M, Iwamoto T, Ikeda H, Taira N, Doihara H. Tsukioki T, et al. Among authors: kochi m. Acta Med Okayama. 2020 Oct;74(5):401-406. doi: 10.18926/AMO/60799. Acta Med Okayama. 2020. PMID: 33106695 Free article.
251 results